Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Other Non-Current Liabilities (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Other Non-Current Liabilities of $61.9 million for Q1 2026, down 2.28% year-over-year from $63.3 million in Q1 2025, and up 1.94% quarter-over-quarter from $60.7 million in Q4 2025.

Stevanato Group S.p.A (STVN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Other Non-Current Liabilities for 7 consecutive years, with $61.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 2.28% year-over-year to $61.9 million; the TTM figure through Mar 2026 stood at $61.9 million (down 2.28% YoY), while the FY2025 annual figure was $60.7 million, up 190.61% from the prior year.
  • Other Non-Current Liabilities grew to $61.9 million in Q1 2026 per STVN's latest filing, from $60.7 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $64.5 million in Q3 2025 and bottomed at -$67.0 million in Q4 2024.
  • Historically, Other Non-Current Liabilities has averaged $28.2 million across 5 years, with a median of $55.3 million in 2024.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities slumped 796.8% — and 2023, when it soared 1798.68%.
  • Stevanato Group S.p.A's Other Non-Current Liabilities stood at -$18.5 million in 2022, then sank by 182.58% to -$52.2 million in 2023, then retreated by 28.4% to -$67.0 million in 2024, then jumped by 190.61% to $60.7 million in 2025, then climbed by 1.94% to $61.9 million in 2026.
  • Business Quant data shows STVN's Other Non-Current Liabilities at $61.9 million in Q1 2026, $60.7 million in Q4 2025, and $64.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 63.86 Mn
Mar 31, 2026 61.89 Mn
Dec 31, 2025 60.71 Mn
Sep 30, 2025 64.48 Mn
Jun 30, 2025 62.93 Mn
Mar 31, 2025 63.33 Mn
Dec 31, 2024 -67.00 Mn
Sep 30, 2024 57.29 Mn
Jun 30, 2024 55.29 Mn
Mar 31, 2024 55.28 Mn
Dec 31, 2023 -52.18 Mn
Sep 30, 2023 56.68 Mn
Jun 30, 2023 36.97 Mn
Mar 31, 2023 22.25 Mn
Dec 31, 2022 -18.47 Mn
Sep 30, 2022 16.13 Mn
Jun 30, 2022 1.95 Mn
Mar 31, 2022 2.04 Mn
Dec 31, 2021 -2.06 Mn
Sep 30, 2021 -2.12 Mn